USPTO serial 79008908
CARNA BIOSCIENCES
Reviewed by CopyMark Law Group
Reg. 3071237Status 706Registered
- Filing date
- Status date
- Registration date
- Mar 21, 2006
- Examiner
- KHOURI, SANI PHILIPPE
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with CARNA BIOSCIENCES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael S. Hargis
Michael S. Hargis Stites & Harbison, PLLC250 West Main Street, Suite 2300Lexington, KY 40507United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Peptide for in vitro research use and for scientific and medical research; polypeptide for in vitro research use and for scientific and medical research; protein for in vitro research use and for scientific and medical research; chemical reagents for non-medical purposes and non-veterinary purposes; and ferments for in vitro research use and for scientific and medical research | ACTIVE | — |
| 005 | Chemical reagents for medical or veterinary purposes [; chemical preparations for medical purposes; chemical preparations for pharmaceutical purposes; diagnostic preparations for medical purposes; drugs for medical purposes for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; medicines for human purposes for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; organotherapy preparations for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; pharmaceutical preparations for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; serotherapeutic medicines for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; pharmaceutical preparations for skin care; biological preparations for medical purposes; and ferments for medical or veterinary use ] | ACTIVE | — |
| 042 | [ Bacteriological research; ] biological research; [ chemical analysis; chemical research; chemistry services; cosmetic research; mechanical research; calibration measuring; and ] biological or chemical research consultancy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CARNA BIOSCIENCES, INC.
- Other trademarks owned by CARNA BIOSCIENCES, INC.
- Other trademarks owned by CARNA BIOSCIENCES, INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named CARNA BIOSCIENCES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 10, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 10, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Mar 10, 2026 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Mar 9, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 10, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Oct 27, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 27, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Oct 27, 2025 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Oct 27, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 27, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 27, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 27, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 21, 2025 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Oct 10, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jan 17, 2019 | RINX | USPTO CORRECTION PROCESSED BY IB | — |
| Sep 13, 2017 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Sep 13, 2017 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| May 5, 2017 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jan 18, 2017 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jan 18, 2017 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Dec 4, 2016 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 4, 2016 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Apr 4, 2016 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Feb 1, 2016 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 13, 2016 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Mar 21, 2015 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Mar 19, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 12, 2015 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Mar 28, 2014 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 13, 2014 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Nov 16, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 12, 2013 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 12, 2012 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jun 12, 2012 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jun 12, 2012 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 16, 2012 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Nov 2, 2007 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 14, 2006 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 24, 2006 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 24, 2006 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 19, 2006 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 21, 2006 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 27, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 7, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 8, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 4, 2005 | ALIE | ASSIGNED TO LIE | — |
| Nov 3, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 19, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Oct 5, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 5, 2005 | PAPER RECEIVED | — | |
| Aug 25, 2005 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 9, 2005 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 9, 2005 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 8, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 4, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 25, 2005 | NWAP | NEW APPLICATION ENTERED | — |
| Mar 24, 2005 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |